2018年糖尿病重要临床进展回顾

Review of important clinical advances in diabetes mellitus in 2018

2018年,美国糖尿病学会(ADA)、欧洲糖尿病研究协会(EASD)、中华医学会糖尿病学分会(CDS)、中国老年医学学会(CGS)及中国微循环学会(CSM)等组织就糖尿病及其并发症发布一系列指南和共识,关于糖尿病分级预防、糖尿病诊断标准、糖尿病患者血压血脂要求、糖尿病患者综合管理、降糖药物的疗效和不良反应等有新的建议和推荐。上述内容对糖尿病的预防、诊断、治疗及糖尿病后续研究都具有重要和深远的意义,对此进行综述。

In 2018,American Diabetes Association(ADA),European Association for the Study of Diabetes(EASD),Chinese Diabetes Society(CDS),Chinese Geriatrics Society(CGS)and Chinese Society of Microcirculation(CSM),etc.published several guidelines and statements on diabetes and its complications.The prevention of diabetes,diagnostic criteria of diabetes,the characteristics of blood pressure and blood lipid,integrated management of diabetes,the efficacy and adverse reaction of hypoglycemic drugs were also suggested and recommended.These guidelines and statements play key roles in the prevention,diagnosis,treatment and future research of diabetes mellitus,which is reviewed in this article.